Trial Profile
Evaluation of exercise capacity of ivacaftor in patients with cystic fibrosis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 13 Jan 2016
Price :
$35
*
At a glance
- Drugs Ivacaftor (Primary)
- Indications Cystic fibrosis
- Focus Therapeutic Use
- 13 Jan 2016 New trial record